However, this difference did not reach statistical significance ( Figure 1B ), which could be due to the limited sample size of our study.
← all excerpts
Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma.
1
—
—